| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 10/31/2006 | US7129307 Functionalized silicon compounds and methods for their synthesis and use |
| 10/31/2006 | US7129227 Herpes, hepatitis and aids virus; administering phosphatides |
| 10/31/2006 | CA2412554C 3-substituted morphines |
| 10/31/2006 | CA2193096C Guanylic acid derivatives and their use as drugs |
| 10/26/2006 | WO2006111058A1 N4- (substituted oxycarbonyl)-2’,2’-difluoro-2’-deoxycytidines and uses thereof |
| 10/26/2006 | WO2006075993A3 Nucleoside derivatives for treating hepatitis c virus infection |
| 10/26/2006 | WO2006015357A3 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity |
| 10/26/2006 | US20060241071 Quaternary ammonium compound having ester and/or amide groups; cationic amphiphilic molecule or macromolecule that transforms from a cationic entity to an anionic, neutral, or zwitterionic entity by a chemical, photochemical, or biological reaction and its use for delivery of nucleic acids |
| 10/26/2006 | US20060241065 Ring-expanded nucleosides and nucleotides |
| 10/26/2006 | US20060241064 Nucleoside compounds for treating viral infections |
| 10/26/2006 | US20060241023 Diabetic therapy; administering to patient an inhibitor of enzymatic conversion of fructose-lysine to fructose-lysine-3-phosphate |
| 10/26/2006 | US20060240529 Process for the preparation of fludarabine phosphate from 2-fluoroadenine and fludarabine phosphate salts with amines or ammonia |
| 10/26/2006 | DE102005019452A1 New 18-fluorine-substituted 3'-deoxythymidine derivatives, useful in positron emission tomography, particularly for detection of brain tumors |
| 10/25/2006 | EP1287532A4 Method for producing ?18 f|fluoride ion |
| 10/25/2006 | EP1016866B1 Novel compound 2-amino-3-[2-(alpha-mannopyranosyl) indol-3-yl] propionic acid, process for preparing the same, and method for inspecting function of living body with the novel compound |
| 10/25/2006 | CN1852915A Purine nucleoside analogues for treating flaviviridae including hepatitis c |
| 10/25/2006 | CN1852914A Novel indolopyrrolocarbazole derivative with antitumor activity |
| 10/25/2006 | CN1852913A Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives |
| 10/25/2006 | CN1281593C Immune regulation and biological therapeutic function of benzo-isoselenazole derivatives |
| 10/24/2006 | US7125983 L-nucleic acid derivatives and process for the synthesis thereof |
| 10/24/2006 | US7125982 Microbial production of nuclease resistant DNA, RNA, and oligo mixtures |
| 10/24/2006 | US7125975 Derivatized oligonucleotides having improved uptake and other properties |
| 10/24/2006 | US7125947 Used to form a functionalized coating on substrate; array of nucleic acids may be covalently attached to substrate to make high density arrays to nucleic acids immobilized on substrate which may be used in high volume nucleic acid hybridization |
| 10/24/2006 | US7125855 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 10/24/2006 | US7125660 Nucleic acid sensor molecules and methods of using same |
| 10/19/2006 | WO2006045616A3 β-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES |
| 10/19/2006 | US20060235219 nucleotides/phosphoramidite linkages; solid phase synthesis |
| 10/19/2006 | US20060234974 2,6-Dihalogeno-8-substituent-purine compound and process for producing the same |
| 10/19/2006 | US20060234963 Hepatitis C therapies |
| 10/19/2006 | US20060234962 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 10/19/2006 | US20060234231 Microarrays displaying encoded molecules |
| 10/18/2006 | EP1712557A1 New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases |
| 10/18/2006 | EP1711825A2 Conjugated small molecules |
| 10/18/2006 | EP1515970B1 Alkynylpurine compounds and production methods thereof |
| 10/18/2006 | EP1062362A4 Levo-monosaccharide in a nucleoside analog for use as an antiretroviral agent |
| 10/18/2006 | EP0948511B1 Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides |
| 10/18/2006 | CN1849142A 2'-branched nucleosides and flaviviridae mutation |
| 10/18/2006 | CN1847256A Antiviral prepn containing both CpG single-strand deoxyoligonucleotide and ribavirin |
| 10/17/2006 | US7122653 Nucleotide sequences coding polypeptide for use in the detection, diagnosis, prevention and classification of prostate tumors |
| 10/17/2006 | US7122528 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 10/17/2006 | US7122526 Topoisomerase I inhibitors; such as 2,3-methylenedioxy-6-hydroxymethyl-9-hydroxy-12-(beta-D-glucopyranosyl) -6,7,12,13-tetrahydroindolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione |
| 10/17/2006 | US7122359 Active-site engineering of nucleotidylyltransferases and general enzymatic methods for the synthesis of natural and “unnatural” UDP- and TDP-nucleotide sugars |
| 10/12/2006 | US20060229275 Production method of 2-deoxy-L-ribofuranosyl chloride compound |
| 10/12/2006 | US20060229264 Crystalline 6-n-pyridylmethylaminoindolocarbazole compounds |
| 10/12/2006 | US20060229263 each case in free form or in salt form; pesticidal compositions in which the active ingredient has been selected from those compounds and their tautomers; and a method of controlling pests using those compositions are described.** Image-1 |
| 10/11/2006 | EP1710249A1 Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound |
| 10/11/2006 | EP1709057A1 Synthesis of spongosine |
| 10/11/2006 | EP1708734A1 HIV gp41 HR2-DERIVED SYNTHETIC PEPTIDES, AND THEIR USE IN THERAPY TO INHIBIT TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS |
| 10/10/2006 | US7119184 Oligonucleotides having A-DNA form and B-DNA form conformational geometry |
| 10/10/2006 | US7119096 Anticancer agents |
| 10/10/2006 | US7118907 Multichannel microfluidic system for sequencing preferential nucleotide sequences |
| 10/10/2006 | US7118871 Reagents for monitoring nucleic acid amplification and methods of using same |
| 10/10/2006 | US7118731 Antitumor agents; anticancer agents; viricides; nucleoside derivative |
| 10/10/2006 | CA2338415C Preparation of thioarabinofuranosyl compounds and use thereof |
| 10/05/2006 | WO2006105529A1 Process for the preparation of 4,6-disubstituted-tetrahydro-furo, thieno, pyrrolo and cyclopenta-[3,4][1,3]dioxoles |
| 10/05/2006 | WO2006058796A3 Methods for preparing enzymatic substrate analogs useful as inhibitors of bacterial heptosyl-transferases and biological applications of the inhibitors |
| 10/05/2006 | WO2004078993A3 Process for preparing dideoxyinosine using adenosine deaminase enzyme |
| 10/05/2006 | US20060223990 Synthesis, deprotection, analysis & purification of RNA & ribozymes |
| 10/05/2006 | US20060223107 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures |
| 10/05/2006 | CA2610854A1 Nicotinamide riboside and analogues thereof |
| 10/04/2006 | EP1707571A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 10/04/2006 | EP1706414A2 Process for fluorocytidine derivatives |
| 10/04/2006 | EP1451178A4 Processes for preparing beta-d-ribofuranose derivatives |
| 10/04/2006 | EP1395266B1 Use of antiviral nucleoside derivatives for the manufacture of a medicament for the treatment of hepatitis c infections |
| 10/04/2006 | CN1842535A Synthesis of beta-l-2'-deoxy nucleosides |
| 10/04/2006 | CN1840538A 1-(2'-deoxy-2'-fluoro-3'-O-amino acid ester-beta-L-furyl arabinosyl)-5-methyl uracil and its application |
| 10/03/2006 | USRE39324 Diagnostic labels for analysis |
| 10/03/2006 | US7115738 Hydroxyproline/phosphono oligonucleotide analogues, methods of synthesis and methods of use |
| 10/03/2006 | US7115585 Compositions for treating epithelial and retinal tissue diseases |
| 10/03/2006 | US7115578 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 10/03/2006 | CA2135039C Solid-phase synthesis of oligoribonucleotides |
| 09/28/2006 | WO2006102594A1 Nucleoside prodrugs for treating viral infections |
| 09/28/2006 | WO2006101911A1 Selective inhibitors of translesion dna replication |
| 09/28/2006 | WO2006100647A1 Hydrogels for the controlled release of bioactive materials |
| 09/28/2006 | WO2006100439A1 Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
| 09/28/2006 | WO2006047842A3 Modified nucleosides for rna interference |
| 09/28/2006 | WO2005121361A3 Sequence-specific detection of methylation in biomolecules |
| 09/28/2006 | WO2005028489A3 Novel adenosine a3 receptor agonists |
| 09/28/2006 | US20060217551 (3R,4R)-1-[(9-deazahypoxanthin-9-yl)methyl]-3-hydroxy-4-hydroxymethyl-pyrrolidine; reaction of formaldehydewith a cyclic amine and a heteroaromatic compound to give methylene linked cyclic amine deazapurines; cancer, bacterial, protozoal infections or T-cell mediated diseases |
| 09/28/2006 | US20060217547 Intermediate and process for preparing of beta- anomer enriched 21-deoxy,21,21-difluoro-D-ribofuranosyl nucleosides |
| 09/28/2006 | US20060217546 3-Deoxypentopyranosyl nucleic acid, its production and its use |
| 09/28/2006 | US20060217345 Beta-L-nucleosides and use thereof as pharmaceutical agents for the treatment of viral diseases |
| 09/28/2006 | US20060217343 2-Polycyclic propynyl adenosine analogs having A2A agonist activity |
| 09/28/2006 | US20060216736 Labeling reagent |
| 09/28/2006 | CA2602324A1 Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
| 09/28/2006 | CA2602000A1 Solid oral dosage form of valopi citabine (val-mcyd) and method of preparing it |
| 09/27/2006 | EP1173222B1 Conjugate having a cleavable linkage for use in a liposome |
| 09/27/2006 | EP1000079B1 New formulation |
| 09/27/2006 | CN1837230A Process for preparing midolthromycin derivatives |
| 09/27/2006 | CN1837169A Compound capable of inhibiting zinc ion metalloproteinases |
| 09/26/2006 | US7112575 Containing adenosine diphosphate and adenosine-2'-monophosphate, adenosine-3'-monophosphate, and/or adenosine-5'-monophosphate; protection from ionizing radiation, especially gamma-rays, x-rays, and beta-particles |
| 09/26/2006 | US7112574 found to be potent adenosine receptor agonists, in particular for the A2A receptor. |
| 09/21/2006 | WO2006098761A2 Hsp90 inhibitors, methods of making and uses therefor |
| 09/21/2006 | WO2006098444A1 Process for production of fluoro derivative |
| 09/21/2006 | WO2006097260A1 Adenosine derivatives having a2a receptor activity |
| 09/21/2006 | US20060211855 Method for the production of oh protected{4-(2.6-diamino-9h-purine-9-yl)-1.3-dioxolane-2-yl] methanol derivatives |
| 09/21/2006 | US20060211634 Antibiotic resistance |
| 09/21/2006 | US20060211045 Fluorescently tagged ligands |
| 09/21/2006 | US20060210452 Very large scale immobilized polymer synthesis |
| 09/21/2006 | DE10152376B4 Fluoreszente Phospholipase A2-Proben und ihre membran-permeablen Derivate Fluorescent phospholipase A2 samples and their membrane-permeable derivatives |